Evaluation of Insulin Glargine Versus Sitagliptin in Insulin-naive Patients

NCT00751114 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

515

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: Insulin Glargine
DRUG: Sitagliptin
DRUG: Metformin

Sponsor

Sanofi